Despite several tumors exhibit upregulated LIF/LIFR-STAT3 signaling via autocrine and paracrine mechanisms, the mechanistic relevance of this pathway and its therapeutic potential in GC remains elusive. This evidence concerns the gene STAT3 and gastric cancer.